Sabby Management’s GlucoTrack GCTK Stock Holding History

Sabby Management’s Portfolio GCTK Stock Details GCTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7	Closed	-$204K	–	48
2024 Q1	$204K	Buy	7 +2	+40%	+$47.1K	0.12%	24
2023 Q4	$112K	Sell	5 -17	-77%	-$338K	0.11%	34
2023 Q3	$526K	Sell	22 -1	-4%	-$27K	0.39%	14
2023 Q2	$702K	Buy	+23	New	+$1.24M	0.57%	14

Other funds holding GCTK

Alerus Financial Grand Forks, North Dakota $2.29B AUM 30.87% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sabby Management's GCTK Position: Q2 2024 in Review

Sabby Management sold out of GlucoTrack (GCTK) in Q2 2024, closing a stake of 7 shares — an estimated $204K sold.

Sabby Management first reported a position in GCTK in Q2 2023 and held it in 4 quarters. The position peaked at $702K in Q2 2023. 2 funds tracked by Wall St. Rank hold GCTK as of Q2 2024.

Sabby Management reported no remaining GlucoTrack position as of Q2 2024 after selling out during the quarter.
Sabby Management sold 7 GlucoTrack shares in Q2 2024, an estimated $204K.
Sabby Management first reported a position in GlucoTrack in Q2 2023 and held it in 4 quarters.
Sabby Management's GlucoTrack position peaked at $702K in Q2 2023.
2 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2024.

Based on Sabby Management's 13F filing for Q2 2024, filed 14 Aug 2024.